Oncotelic Advances Late-Stage Oncology Pipeline into 2026
Agoura Hills, California — February 10, 2026: Oncotelic Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on oncology, immunotherapy, and...
translational science
Advertisement
Single-Molecule Proteomics Targets Alpha-Synuclein in Parkinson’s
January 28, 2026 — Nautilus Biotechnology, Weill Cornell Medicine–Qatar (WCM-Q), and The Michael J. Fox Foundation (MJFF) have launched...
NIH Awards $1.9M to RFU for Neurological Disease Research
North Chicago, Illinois, January 20, 2026 — A researcher at Rosalind Franklin University of Medicine and Science (RFU) has...
Concept Life Sciences Appoints Adam Davenport as CSO
CHAPEL-EN-LE-FRITH, United Kingdom | January 19, 2026 — Concept Life Sciences, a leading global contract research organization (CRO) specializing...
Mondego Bio Names PTPN2 Inhibitor for First-in-Human Study
CANTANHEDE, Portugal — December 22, 2025 — Mondego Bio has announced the formal selection of ZE00-0388, a highly selective...
Advertisements
NIH Backs RFU Research on Social Deficits in Schizophrenia, ASD
December 18, 2025 | North Chicago, Illinois — Rosalind Franklin University of Medicine and Science has secured $1.73 million...
Advertisement
